Dietary Macronutrients Do Not Differently Influence Postprandial Serum and Plasma Brain-Derived Neurotrophic Factor Concentrations: A Randomized, Double-Blind, Controlled Cross-Over Trial

Elske Gravesteijn, Ronald P Mensink, Ellen T H C Smeets, Jogchum Plat, Elske Gravesteijn, Ronald P Mensink, Ellen T H C Smeets, Jogchum Plat

Abstract

Objectives: Brain-derived neurotrophic factor (BDNF) plays a role in cognition and metabolism. Specific nutrients can affect fasting BDNF concentrations, which are potentially mediated by insulin and/or glucose. Since macronutrients trigger each a different insulin and glucose response, we examined postprandial effects of meals rich in fat, carbohydrates, or protein on BDNF concentrations. BDNF was analyzed in serum and plasma, since concentration differences can be found between matrices. Methods: Healthy overweight/obese male participants (n = 18) participated in this randomized, double-blind, cross-over trial consisting of three test days with 1 week wash-out periods. Either a high-fat (En% fat, carbohydrates, protein: 52.3, 39.2, 8.0), high-carbohydrate (En% 9.6, 81.5, 8.6) or high-protein meal (En% 10.6, 51.5, 36.9) was consumed on each test day. BDNF concentrations were measured after 0, 60, and 240 min. Glucose and insulin concentrations were measured after 0, 15, 30, 45, 60, 90, 120, and 240 min. Results: BDNF concentrations were higher in serum compared with plasma (P < 0.001). Postprandial BDNF concentrations in serum decreased significantly after the high-fat (P = 0.013) and high-carbohydrate meals (P = 0.040), and showed a trend after the high-protein meal (P = 0.076). No differences were found between meals (P = 0.66). Postprandial BDNF concentrations measured in plasma did not significantly change after the different meals (P = 0.47). As total area under the curve (AUC) for glucose was significantly higher after the high-carbohydrate meal compared with the high-fat (P = 0.003) and high-protein meals (P < 0.001), and the total AUC for insulin was higher after the high-carbohydrate (P < 0.001) and high-protein meals (P < 0.001) compared with the high-fat meal, it seems that acute changes in glucose and insulin do not affect postprandial BDNF concentrations. However, after the high-protein meal, the higher total AUC for glucose correlated with lower serum BDNF concentrations, and a higher maximal increase in glucose correlated with a lower maximal increase in plasma BDNF concentrations. There were no correlations with insulin concentrations after either meal. Conclusion: Serum BDNF concentrations were higher than plasma concentrations. Since postprandial BDNF responses were not different between the meals, we conclude that there is no role for insulin or glucose in regulating postprandial BDNF concentrations. Clinical Trial Registration: [www.ClinicalTrials.gov], identifier [NCT03139890].

Keywords: brain-derived neurotrophic factor (BDNF); human intervention; macronutrients; metabolism; plasma; postprandial; serum.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Gravesteijn, Mensink, Smeets and Plat.

Figures

FIGURE 1
FIGURE 1
Postprandial mean changes (±SD) in BDNF concentrations (pg/ml) after consumption of the high-fat (solid line), high-carbohydrate (dashed line) and high-protein (dotted line) meal in serum (A) and EDTA plasma (B).

References

    1. Ahuja K. D., Adams M. J., Robertson I. K., Ball M. J. (2009). Acute effect of a high carbohydrate low fat meal on platelet aggregation. Platelets 20 606–609. 10.3109/09537100903267517
    1. Boyuk B., Degirmencioglu S., Atalay H., Guzel S., Acar A., Celebi A., et al. (2014). Relationship between Levels of brain-derived neurotrophic factor and metabolic parameters in patients with type 2 diabetes mellitus. J. Diabetes Res. 2014:978143. 10.1155/2014/978143
    1. Civelek S., Konukoglu D., Erdenen F., Uzun H. (2013). Serum neurotrophic factor levels in patients with type 2 diabetes mellitus: relationship to metabolic syndrome components. Clin. Lab. 59 369–374. 10.7754/clin.lab.2012.120404
    1. de Luis D. A., Fernandez Ovalle H., Izaola O., Primo D., Aller R. (2018). RS 10767664 gene variant in Brain Derived Neurotrophic Factor (BDNF) affect metabolic changes and insulin resistance after a standard hypocaloric diet. J. Diabetes Complications. 32 216–220. 10.1016/j.jdiacomp.2017.10.005
    1. Dresner A., Laurent D., Marcucci M., Griffin M. E., Dufour S., Cline G. W., et al. (1999). Effects of free fatty acids on glucose transport and IRS-1–associated phosphatidylinositol 3-kinase activity. J. Clin. Invest. 103 253–259. 10.1172/JCI5001
    1. Eyileten C., Kaplon-Cieslicka A., Mirowska-Guzel D., Malek L., Postula M. (2017). Antidiabetic effect of brain-derived neurotrophic factor and its association with inflammation in type 2 diabetes mellitus. J. Diabetes Res. 2017:2823671. 10.1155/2017/2823671
    1. Foulstone E. J., Tavaré J. M., Gunn-Moore F. J. (1999). Sustained phosphorylation and activation of protein kinase B correlates with brain-derived neurotrophic factor and insulin stimulated survival of cerebellar granule cells. Neurosci. Lett. 264 125–128. 10.1016/s0304-3940(99)00166-4
    1. Fujinami A., Ohta K., Obayashi H., Fukui M., Hasegawa G., Nakamura N., et al. (2008). Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: relationship to glucose metabolism and biomarkers of insulin resistance. Clin. Biochem. 41 812–817. 10.1016/j.clinbiochem.2008.03.003
    1. Gravesteijn E., Mensink R. P., Plat J. (2021). Effects of nutritional interventions on BDNF concentrations in humans: a systematic review. Nutr. Neurosci. 1–12. Online ahead of print, 10.1080/1028415X.2020.1865758
    1. Karczewska-Kupczewska M., Kowalska I., Nikolajuk A., Adamska A., Zielinska M., Kaminska N., et al. (2012). Circulating brain-derived neurotrophic factor concentration is downregulated by intralipid heparin infusion or high-fat meal in young healthy male subjects. Diabetes Care 35 358–362. 10.2337/dc11-1295
    1. Krabbe K. S., Nielsen A. R., Krogh-Madsen R., Plomgaard P., Rasmussen P., Erikstrup C., et al. (2007). Brain-Derived Neurotrophic Factor (BDNF) and type 2 diabetes. Diabetologia 50 431–438.
    1. Kuroda A., Yamasaki Y., Matsuhisa M., Kubota M., Nakahara I., Nakatani Y., et al. (2003). Brain-derived neurotrophic factor ameliorates hepatic insulin resistance in zucker fatty rats. Metabolism 52 203–208. 10.1053/meta.2003.50026
    1. Lee I. T., Chen C. H., Wang J. S., Fu C. P., Lee W. J., Liang K. W., et al. (2018). The association between brain-derived neurotrophic factor and central pulse pressure after an oral glucose tolerance test. Clin. Chim. Acta. 476 1–8. 10.1016/j.cca.2017.10.023
    1. Lee I. T., Li Y. H., Sheu W. H. (2020). Brain-derived neurotrophic factor during oral glucose tolerance test predicts cardiovascular outcomes. Int. J. Mol. Sci. 21:5008. 10.3390/ijms21145008
    1. Li B., Lang N., Cheng Z. F. (2016). Serum levels of brain-derived neurotrophic factor are associated with diabetes risk, complications, and obesity: a cohort study from chinese patients with type 2 diabetes. Mol. Neurobiol. 53 5492–5499. 10.1007/s12035-015-9461-2
    1. Liu W., Han X., Zhou X., Zhang S., Cai X., Zhang L., et al. (2016). Brain derived neurotropic factor in newly diagnosed diabetes and prediabetes. Mol. Cell Endocrinol. 429 106–113. 10.1016/j.mce.2016.04.002
    1. Marosi K., Mattson M. P. (2014). BDNF mediates adaptive brain and body responses to energetic challenges. Trends Endocrinol. Metab. 25 89–98. 10.1016/j.tem.2013.10.006
    1. McAllister A. K., Katz L. C., Lo D. C. (1999). Neurotrophins and synaptic plasticity. Annu. Rev. Neurosci. 22 295–318.
    1. Miranda M., Morici J. F., Zanoni M. B., Bekinschtein P. (2019). Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain. Front. Cell Neurosci. 13:363. 10.3389/fncel.2019.00363
    1. Nuttall F. Q., Gannon M. C. (1991). Plasma glucose and insulin response to macronutrients in nondiabetic and NIDDM subjects. Diabetes Care 14 824–838. 10.2337/diacare.14.9.824
    1. Onbaşi K., Efe B., Çeler Ö. (2016). Postprandial phase fluctuations can trigger the coagulation cascade. Int. J. Clin. Exp. Med. 9 5891–5901.
    1. Rosenfeld R. D., Zeni L., Haniu M., Talvenheimo J., Radka S. F., Bennett L., et al. (1995). Purification and identification of brain-derived neurotrophic factor from human serum. Protein Expr. Purif. 6 465–471. 10.1006/prep.1995.1062
    1. Rozanska O., Uruska A., Zozulinska-Ziolkiewicz D. (2020). Brain-derived neurotrophic factor and diabetes. Int. J. Mol. Sci. 21:841. 10.3390/ijms21030841
    1. Shafie A., Rahimi A. M., Ahmadi I., Nabavizadeh F., Ranjbaran M., Ashabi G. (2020). High-protein and low-calorie diets improved the anti-aging klotho protein in the rats’ brain: the toxic role of high-fat diet. Nutr. Metab. 17:86. 10.1186/s12986-020-00508-1
    1. Silveira A. (2001). Postprandial triglycerides and blood coagulation. Exp. Clin. Endocrinol. Diabetes 109 S527–S532. 10.1055/s-2001-15115
    1. Sinzinger H., Berent R. (2012). Platelet function in the postprandial period. Thromb J. 10:19. 10.1186/1477-9560-10-19
    1. Spectre G., Ostenson C. G., Li N., Hjemdahl P. (2012). Postprandial platelet activation is related to postprandial plasma insulin rather than glucose in patients with type 2 diabetes. Diabetes 61 2380–2384. 10.2337/db11-1806
    1. Suwa M., Kishimoto H., Nofuji Y., Nakano H., Sasaki H., Radak Z., et al. (2006). Serum brain-derived neurotrophic factor level is increased and associated with obesity in newly diagnosed female patients with type 2 diabetes mellitus. Metabolism 55 852–857. 10.1016/j.metabol.2006.02.012
    1. Yamanaka M., Itakura Y., Inoue T., Tsuchida A., Nakagawa T., Noguchi H., et al. (2006). Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice. Metabolism 55 1286–1292. 10.1016/j.metabol.2006.04.017
    1. Zeeni N., Haidar E. A., Azar A., Ghanem A., Bassil K., Bassil M., et al. (2018). The combinatory effects of diet and exercise on BDNF gene expression. FASEB J. 31:150.8.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner